Article Information
PubMed
Published By
History
- Received October 30, 2017
- Revision received July 5, 2018
- Accepted July 9, 2018
- Published online July 30, 2018.
Copyright & Usage
Copyright © 2018 de la Parra et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
Author Information
- Juan de la Parra1,*,
- María I. Cuartero1,*,
- Alberto Pérez-Ruiz1,
- Alicia García-Culebras1,
- Ricardo Martín2,
- José Sánchez-Prieto2,
- Juan M. García-Segura3,
- Ignacio Lizasoain1 and
- María A. Moro1
- 1Unidad De Investigación Neurovascular, Dpto. Farmacología y Toxicología, Facultad De Medicina, and Instituto Universitario De Investigación En Neuroquímica (IUIN), Universidad Complutense De Madrid (UCM); Instituto De Investigación Hospital 12 De Octubre (i+12), Madrid, Spain
- 2Departamento De Bioquímica y Biología Molecular, Facultad De Veterinaria and IUIN, UCM, Madrid, Spain
- 3Departamento De Bioquímica y Biología Molecular, Facultad De Ciencias Químicas, and IUIN, UCM, Madrid, Spain
- Correspondence should be addressed to either of the following: María A. Moro, Unidad de Investigación Neurovascular, Departamento de Farmacología, Facultad de Medicina, Universidad Complutense, Avenida Complutense s/n, 28040 Madrid, Spain. E-mail: neurona{at}ucm.es; or María I. Cuartero, Unidad de Investigación Neurovascular, Departamento de Farmacología, Facultad de Medicina, Universidad Complutense, Avenida Complutense s/n, 28040 Madrid, Spain. E-mail: maribel_cd{at}hotmail.com.
Author contributions
Author Contributions: JdlP, MIC, and MAM designed research; JdlP, MIC, APR, AGC, and RM performed research; JdlP, MIC, RM, JSP, JMGS, IL, and MAM analyzed data; JdlP, MIC, and MAM wrote the paper.
Disclosures
The authors declare no competing financial interests.
This work was supported by grants from Spanish Ministry of Economy and Competitiveness SAF2015-68632-R (MAM) and SAF2016-81716-REDC (MAM), from Instituto de Salud Carlos III, and from Regional Madrid Government B2017/BMD-3688 (IL) and cofinanced by Fondo Europeo de Desarrollo Regional (FEDER) «Una manera de hacer Europa» PI17/01601 (IL) and RD16/0019/0009 (IL).
↵* J. de la Parra and M.I. Cuartero contributed equally to this work.
Funding
Spanish Ministry of Economy and Competitiveness
SAF2015-68632-R; SAF2016-81716-REDCInstituto de Salud Carlos III and Fondo Europeo de Desarrollo Regional (FEDER)
RETICS RD16/0019/0009MINECO | Instituto de Salud Carlos III (ISCIII)
PI17/01601Consejería de Educación, Juventud y Deporte, Comunidad de Madrid (Ministry of Education, Youth and Sports, Government of Madrid)
B2017/BMD-3688
Other Version
- You are viewing the most recent version of this article.
- previous version (July 30, 2018).
Online Impact